Veracyte Inc
NASDAQ:VCYT 4:00:00 PM EDT
Market Cap (Intraday) | 1.46B |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $19.77 |
50-Day MA | $22.22 |
200-Day MA | $24.41 |
Veracyte Inc Stock, NASDAQ:VCYT
6000 Shoreline Court, Suite 300, South San Francisco, California 94080
United States of America
Phone: +1.650.243.6300
Number of Employees: 815
Description
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.